Altimmune (ALT) Enterprise Value Growth (3y) (2013 - 2026)
Altimmune (ALT) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Altimmune |
336.67 Mn |
336.67 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
16.17% |
| Dec 31, 2025 |
-34.99% |
| Sep 30, 2025 |
-18.24% |
| Jun 30, 2025 |
-10.45% |
| Mar 31, 2025 |
5.93% |
| Dec 31, 2024 |
42.07% |
| Sep 30, 2024 |
11.32% |
| Jun 30, 2024 |
8.86% |
| Mar 31, 2024 |
7.03% |
| Dec 31, 2023 |
14.45% |
| Sep 30, 2023 |
15.40% |
| Jun 30, 2023 |
-25.85% |
| Mar 31, 2023 |
-71.34% |
| Dec 31, 2022 |
-43.94% |
| Sep 30, 2022 |
-48.14% |
| Jun 30, 2022 |
-48.22% |
| Mar 31, 2022 |
-58.08% |
| Dec 31, 2021 |
-75.88% |
| Sep 30, 2021 |
-191.97% |
| Jun 30, 2021 |
-243.95% |
